Abstract
Vaccinations are fundamental public health interventions. Yet, inequalities in vaccines uptake across socioeconomic groups can significantly undermine their impact. Moreover, heterogeneities in vaccination coverage across socioeconomic strata are typically neglected by epidemic models and considered, if at all, only at posteriori. This limitation reduces their ability to predict and assess the effectiveness of vaccination campaigns. Here, we study the impact of socioeconomic inequalities in vaccination uptake on epidemic burden. We consider a modeling framework based on generalized contact matrices that extend traditional age-stratified approaches to incorporate socioeconomic status (SES) variables. We simulate epidemic dynamics under two scenarios. In the first vaccination campaigns are concurrent with epidemics. In the second instead, vaccinations are completed before the onset of infection waves. By using both synthetic and empirical generalized contact matrices, we find that inequalities in vaccine uptake can lead to non-linear effects on disease outcomes and exacerbate disease burden in disadvantaged groups of the population. We demonstrate that simple models ignoring SES heterogeneity produce incomplete or biased predictions of epidemic burden. Additionally, we show how inequalities in vaccine coverage interact with non-pharmaceutical interventions (NPIs) compounding differences across subgroups. Overall, our findings highlight the importance of integrating SES dimensions, alongside age, into epidemic models to inform more equitable and effective public health interventions and vaccination strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.M. and M.K. were supported by the Accelnet-Multinet NSF grant. A.M. is grateful for the support from CEU and NetSI (Northeastern University). M.K. acknowledges support from the ANR project DATAREDUX (ANR-19-CE46-0008); the SoBigData++ H2020-871042; the EMOMAP CIVICA projects; and the National Laboratory for Health Security, Alfred Renyi Institute, RRF-2.3.1-21-2022-00006.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data collection adhered to European and Hungarian privacy regulations, approved by the Hungarian National Authority for Data Protection and Freedom of Information, as well as the Health Science Council Scientific and Research Ethics Committee (resolution number IV/3073-1/2021/EKU)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials.
